Aurobindo Pharma’s US based arm initiates recall of Gabapentin capsules

25 Nov 2014 Evaluate

Aurobindo Pharma’s American arm Aurobindo Pharma USA, Inc. has initiated a voluntary recall of Gabapentin capsules, which are used in the treatment of epilepsy, of a particular lot in the US market as some of the capsules were found to be empty. The empty capsules could have adverse health consequences that can range from having no effect to a short term reduction in efficiency.

The company received the American drug regulator's approval to manufacture and market the product in October 2011. The affected Gabapentin lot, GESB14011-A, expires on December 2015 and is packaged in 100-count bottles.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×